Antiplasmodial effects of a few selected natural flavonoids and their modulation of artemisinin activity

Natural Product Communications

Volumn 3, Issue 12, 2008, Pages 1999-2002

  Bilia, Anna Rita ^a   Sannella, Anna Rosa ^b   Vincieri, Franco Francesco ^a   Messori, Luigi ^a   Casini, Angela ^a   Gabbiani, Chiara ^a   Severini, Carlo ^b   Majori, Giancarlo ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

Additive and synergistic effects; Artemisinin; Eriodictyol; Eriodictyolchalcone and catechin; Flavonoids; Plasmodium falciparum; Quercetin; Rutin

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; CATECHIN; ERIODICTYOL; ERIODICTYOLCHALCONE; FLAVONOID; QUERCETIN; RUTOSIDE; UNCLASSIFIED DRUG;

ANTIMALARIAL ACTIVITY; ARTICLE; DRUG EFFECT; DRUG POTENTIATION; GROWTH INHIBITION; IN VITRO STUDY; NONHUMAN; PLASMODIUM FALCIPARUM; STRUCTURE ANALYSIS;

PLASMODIUM FALCIPARUM;

EID: 77952810958     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x0800301212     Document Type: Article

References (24)

1. Tu Y. (2004) The development of the antimalarial drugs with new type of chemical structure-qinghaosu and dihydroqinghaosu. Southeast Asian Journal of Tropical Medicine and Public Health, 35, 250-251. (Pubitemid 39248695)
2. Balint GA. (2001) Artemisinin and its derivatives: an important new class of antimalarial agents. Pharmacology and Therapy, 90, 261-265.
3. Dhingra V, Vishweshwar Rao K, Lakshmi Narasu M. (2000) Current status of artemisinin and its derivatives as antimalarial drugs. Life Sciences, 66, 279-300. (Pubitemid 30025481)
4. Price RN, Nosten F, Luxemburger C, Kuile FO, Paiphun L, Chongsuphajaisiddhi T, White NJ. (1996) Effects of artemisinin derivatives on malaria transmissibility. Lancet, 347, 1654-1658.
5. Targett G, Drakeley C, Jawara M, von Seidlein L, Coleman R, Deen J, Pinder M, Doherty T, Sutherland C, Walraven G, Milligan P. (2001) Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. Journal of Infections and Diseases, 183, 1254-1259.
6. Udomsangpetch R, Pipitaporn B, Krishna S, Angus B, Pukrittayakamee S, Bates I, Suputtamongkol Y, Kyle DE, White NJ. (1996) Antimalarial drugs reduce cytoadherence and rosetting Plasmodium falciparum. Journal of Infections and Diseases, 173, 691-698.
7. O'Neill PM, Posner GH. (2004) A medicinal chemistry perspective on artemisinin and related endoperoxides. Journal of Medicinal Chemistry, 47, 2945-2964.
8. Haynes RK., Krishna S. (2004) Artemisinins: activities and actions. Microbes and Infections, 6, 1339-1346.
9. Cazelles J., Robert A, Meunier B. (2002) Alkylating capacity and reaction products of antimalarial trioxanes after activation by a heme model. Journal of Organic Chemistry, 67, 609-619.
10. Robert A, Coppel Y, Meunier B. (2002) Alkylation of heme by the antimalarial drug artemisinin. Chemical Communications, 414-415. (Pubitemid 34252451)
11. Robert A, Dechy-Cabaret O, Cazelles J, Meunier B. (2002) From mechanistic studies on artemisinin derivatives to new modular antimalarial drugs.Accademy of Chemical Research, 35, 167-174.
12. Robert A, Benoit-Vical F, Claparols C, Meunier B. (2005) The antimalarial drug artemisinin alkylates heme in infected mice. Procedings of the National Academy of Sciences of the United States of America, 102, 13676-13680.
13. Messori L, Piccioli F, Eitler B, Bergonzi MC, Bilia AR, Vincieri FF. (2003) Spectrophotometric and ESI-MS/HPLC studies reveal a common mechanism for the reaction of various artemisinin analogues with hemin. Bioorganic and. Medicinal Chemistry Letters, 13, 4055-4057.
14. Messori L, Gabbiani C, Casini A, Siragusa M, Vincieri FF, Bilia AR. (2006) The reaction of artemisinins with hemoglobin: a unified picture. Bioorganic and. Medicinal Chemistry, 14, 2972-2977.
15. Eckstein-Ludwig U, Webb RJ, Van Goethem ID, East JM, Lee AG, Kimura M, O'Neill PM, Bray PG, Ward SA, Krishna S. (2003) Artemisinins target the SERCA of Plasmodium falciparum. Nature, 424, 887-889.
16. World Health Organization, 2001. Antimalarial Drug Combination Therapy: Report of a Technical Consultation. WHO, Geneva.
17. Sannella AR, Messori L, Casini A, Vincieri FF, Bilia AR, Majori G, Severini C. (2007) Antimalarial properties of green tea. Biochemical and Biophysical Research Communications, 353, 177-181.
18. Bilia AR. (2006) Non-nitrogenous plant-derived constituents with antiplasmodial activity. Natural Product Communications, 1, 1181-1204.
19. Lu J, Papp LV, Fang J, Rodriguez-Nieto S, Zhivotovsky B, Holmgren A. (2006) Inhibition of mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity. Cancer Research, 66, 4410-4418.
20. Bell A. (2005) Antimalarial drug synergism and antagonism: mechanistic and clinical significance. FEMS Microbiological Letters, 253, 171-184.
21. Trager W, Jensen JB. (1976) Human malaria parasites in continuous culture. Science, 93, 673-675.
22. Makler MT, Ries JM, Williams JA, Bancroft JE, Piper RC, Gibbins BL, Hinrichs DJ. (1993) Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity. American Journal of Tropical Medicine and Hygiene, 48, 739-741. (Pubitemid 23238452)
23. Lambros C, Vanderberg JP. (1979) Synchronization of Plasmodium falciparum erythrocytic stages in culture. Journal of Parasitology, 65, 418-420.
24. Severini C, Menegon M, Sannella AR, Paglia MG, Narciso P, Matteelli A, Gulletta M, Caramello P, Canta F, Xayavong MV, Moura INS, Pieniazek NJ, Taramelli D, Majori G. (2006) Prevalence of pfcrt point mutations and level of cloroquine resistance in Plasmodium falciparum isolates from Africa, Infections and Genetic Evolution, 6, 262-268.